Accelerated Approval Is Delivering for Patients Read more about Accelerated Approval Is Delivering for Patients
The Inaugural HEMA Report: A Missed Opportunity for Comprehensive Value Assessment Read more about The Inaugural HEMA Report: A Missed Opportunity for Comprehensive Value Assessment
How Much? Addressing Medicines’ Cost and Value Read more about How Much? Addressing Medicines’ Cost and Value
HEMA’s Inaugural Report Misses the Mark for U.S. Patients Read more about HEMA’s Inaugural Report Misses the Mark for U.S. Patients
American Patients vs Foreign Governments — A Tale of 2 Value Sets Read more about American Patients vs Foreign Governments — A Tale of 2 Value Sets
Patient Engagement in Managed Care Pharmacy: Putting Policy Into Practice Read more about Patient Engagement in Managed Care Pharmacy: Putting Policy Into Practice
New Commentary in JMCP — Patient Engagement in Managed Care Pharmacy: Putting Policy Into Practice Read more about New Commentary in JMCP — Patient Engagement in Managed Care Pharmacy: Putting Policy Into Practice
NPC Submits Comments to HEMA on Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies Read more about NPC Submits Comments to HEMA on Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies
Heavy on Price, Light on Access: ICER’s Launch Price and Access Report Misses the Mark Read more about Heavy on Price, Light on Access: ICER’s Launch Price and Access Report Misses the Mark
Inflation-Adjusted Analysis of ICER's Unsupported Price Increase Reports: Contextualizing Drug Spending Changes Read more about Inflation-Adjusted Analysis of ICER's Unsupported Price Increase Reports: Contextualizing Drug Spending Changes